Delve Bio
Pre-clinicalDelve Bio leverages mNGS to empower labs and clinicians with the results they need to diagnose routine and rare infectious diseases.
Founded
2019
Focus
DiagnosticsGenetics & Genomics
About
Delve Bio leverages mNGS to empower labs and clinicians with the results they need to diagnose routine and rare infectious diseases.
Funding History
2Total raised: $105M
Series A$70MSection 32Oct 15, 2023
Seed$35MAndreessen HorowitzMar 15, 2022
Company Info
TypePrivate
Founded2019
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile